As of 2025-07-07, the Intrinsic Value of Neurones SA (NRO.PA) is 39.90 EUR. This NRO.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 45.05 EUR, the upside of Neurones SA is -11.40%.
The range of the Intrinsic Value is 28.95 - 66.70 EUR
Based on its market price of 45.05 EUR and our intrinsic valuation, Neurones SA (NRO.PA) is overvalued by 11.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 28.95 - 66.70 | 39.90 | -11.4% |
| DCF (Growth 10y) | 34.50 - 75.59 | 46.53 | 3.3% |
| DCF (EBITDA 5y) | 33.77 - 40.24 | 36.81 | -18.3% |
| DCF (EBITDA 10y) | 38.97 - 49.39 | 43.76 | -2.9% |
| Fair Value | 24.99 - 24.99 | 24.99 | -44.53% |
| P/E | 41.26 - 50.67 | 45.67 | 1.4% |
| EV/EBITDA | 32.38 - 44.52 | 38.85 | -13.8% |
| EPV | 108.30 - 143.90 | 126.10 | 179.9% |
| DDM - Stable | 20.32 - 63.21 | 41.76 | -7.3% |
| DDM - Multi | 34.95 - 80.08 | 48.18 | 6.9% |
| Market Cap (mil) | 1,093.81 |
| Beta | 0.43 |
| Outstanding shares (mil) | 24.28 |
| Enterprise Value (mil) | 1,092.43 |
| Market risk premium | 5.82% |
| Cost of Equity | 8.27% |
| Cost of Debt | 5.00% |
| WACC | 8.10% |